Cevian Capital II GP LTD 13F: Quarter-over-Quarter Portfolio Changes
Cevian Capital II GP LTD reported a disclosed portfolio value of approximately $3.7 billion in its latest SEC Form 13F-HR filing for Q2 2026, up 18.6% quarter on quarter. Over the quarter, the fund trimmed 1 holding.
Cevian Capital II GP LTD's top sell was Crh PLC (CRH) . The fund sold 0.8% of its previously reported shares, reducing the position's portfolio weight by 2.7 percentage points.
Top SellsQ2 2026
The fund's top sells among positions it retained in Q2 2026. Ranked by portfolio-weight impact. Full exits are listed separately.
Net Portfolio Value ChangeQ2 2026
- $3.1BPrior quarter
- $3.7BCurrent quarter
- +$0.6BNet delta
- +18.6%% change
Methodology & FAQ
How Cevian Capital II GP LTD Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for Cevian Capital II GP LTD: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.
What stocks did Cevian Capital II GP LTD buy in Q2 2026?
Cevian Capital II GP LTD reported no new positions or share-count increases in its Q2 2026 13F filing.
What stocks did Cevian Capital II GP LTD sell in Q2 2026?
In Q2 2026, Cevian Capital II GP LTD reduced holdings in CRH PLC (CRH).
Which positions did Cevian Capital II GP LTD initiate in Q2 2026?
Cevian Capital II GP LTD established no new positions in Q2 2026.
Which existing positions saw the largest allocation increases for Cevian Capital II GP LTD in Q2 2026?
Cevian Capital II GP LTD reported no material allocation increases in existing positions in Q2 2026.
Which positions did Cevian Capital II GP LTD fully exit in Q2 2026?
Cevian Capital II GP LTD fully exited no positions in Q2 2026.
Which existing positions saw the largest allocation reductions for Cevian Capital II GP LTD in Q2 2026?
Of 1 existing position with share-count reductions in Q2 2026, the largest were: CRH PLC (CRH, -2.7% weight, -0.8% shares).
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.